Chikungunya encephalitis: A case report

Abstract

Rationale: Transmitted to humans via the Aedes mosquito, Chikungunya virus (CHIKV) is associated with multi-system complications, sometimes collectively referred to as “atypical features.” However, a disorder of the nervous system appears to be the most common severe complication of CHIKV infection. Patient’s Concern: A seventy-five-year-old patient from India presented to the hospital with fever, chills, rigors, and multiple joint pains for which he was worked up. Diagnosis: CHIKV encephalitis. Interventions: The patient was treated initially on supportive therapy with antipyretics, intravenous fluids; however, during his hospital stay, the patient had altered sensorium during which he was managed in the intensive care unit; required mechanical ventilation. Outcomes: The patient sccumbed to his illness. Lessons: Treating clinicians should keep CHIKV disease in the differential diagnosis in cases of febrile exanthems associated with disabling arthritis, especially in a CHIKV-endemic country like India.

Keywords

Chikungunya / Rash / CHIKV encephalitis / Polyarthritis

References

[1] Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli A, Panning M, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370(9602): 1840-1846.

[2] Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito—borne disease. N Engl J Med 2015; 372(13): 1231-1239.

[3] Morrison TE. Reemergence of chikungunya virus. J Virol 2014; 88(20): 11644-11647.

[4] Translational Research Consortia (TRC) for Chikungunya Virus in India. Current Status of Chikungunya in India. Front Microbiol 2021; 12: 695173.

[5] Miner JJ, Aw—Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST, et al. Chikungunya viral arthritis in the United States: A mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol 2015; 67(5): 1214-1220.

[6] Tini ML, Rezza G. Morbilliform skin rash with prominent involvement of the palms in Chikungunya fever. IDCases 2018; 13: e00421.

[7] Centers for Disease Control and Prevention. Chikungunya virus: Clinical evaluation & disease. [Online] Available from: https://www.cdc.gov/chikungunya/hc/clinicalevaluation.html [Accessed on August 1, 2023].

[8] Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, et al. Chikungunya virus—associated long—term arthralgia: a 36—month prospective longitudinal study. PLoS Negl Trop Dis 2013; 7: e2137.

[9] Mavalankar D, Shastri P, Bandyopadhyay T, Parmar J, Ramani KV. Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis 2008; 14(3): 412-415.

[10] Dorléans F, Hoen B, Najioullah F, Herrmann—Storck C, Schepers KM, Abel S et al. Outbreak of Chikungunya in the French Caribbean Islands of Martinique and Guadeloupe: Findings from a hospital—based surveillance system (2013—2015). Am J Trop Med Hyg 2018; 98(6): 1819-1825.

[11] Gérardin P, Sampériz S, Ramful D, Boumahni B, Bintner M, Alessandri JL et al. Neurocognitive outcome of children exposed to perinatal mother—to—child Chikungunya virus infection: The CHIMERE cohort study on Reunion Island. PLoS Negl Trop Dis 2014; 8: e2996.

[12] Robin S, Ramful D, Le Seach' F, Jaffar—Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol 2008; 23(9): 1028-1035.

[13] Gérardin P, Couderc T, Bintner M, Tournebize P, Renouil M, Lémant J, et al. Encephalchik Study Group. Chikungunya virus—associated encephalitis: A cohort study on La Réunion Island, 2005—2009. Neurology 2016; 86(1): 94-102.

[14] Rodriguez—Morales AJ, Villamil—Gomez WE, Franco—Paredes C. The arboviral burden of disease caused by co—circulation and co—infection of dengue, chikungunya and Zika in the Americas. Travel Med Infect Dis 2016; 14(3): 1779.

[15] Webb E, Michelen M, Rigby I, Dagens A, Dahmash D, Cheng V et al. An evaluation of global Chikungunya clinical management guidelines: A systematic review. EClinicalMedicine 2022; 54: 101672.